Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.02.2023 | Case report

Rituximab

Mild allergic reaction, pneumonia and anaphylaxis: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ashoor I, et al. Pre-Emptive Rituximab to Prevent Post Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Kidney Transplant Recipients with EBV DNAemia: A Case Series from the Pediatric Nephrology Research Consortium (PNRC). American Journal of Transplantation 22 (Suppl. 3): 379 abstr. 105, Jun 2022. Available from: URL: http://doi.org/10.1111/ajt.17072 [abstract] Ashoor I, et al. Pre-Emptive Rituximab to Prevent Post Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Kidney Transplant Recipients with EBV DNAemia: A Case Series from the Pediatric Nephrology Research Consortium (PNRC). American Journal of Transplantation 22 (Suppl. 3): 379 abstr. 105, Jun 2022. Available from: URL: http://​doi.​org/​10.​1111/​ajt.​17072 [abstract]
Metadaten
Titel
Rituximab
Mild allergic reaction, pneumonia and anaphylaxis: 3 case reports
Publikationsdatum
01.02.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-33470-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Voriconazole

Case report

Linezolid

Case report

Multiple drugs

Case report

COVID-19 vaccine